Viemed Healthcare Outlines Growth Strategy Focused on Home Ventilation Market Expansion
At the Midwest IDEAS Conference, Viemed Healthcare (NASDAQ:VMD) outlined its growth strategy centered around expanding in-home care for patients with complex respiratory conditions. CEO Casey Hoyt highlighted that half of the company's business is dedicated to these services and emphasized a significant opportunity in home ventilation therapy for severe COPD patients. Hoyt noted an estimated 10% of America’s 25 million COPD sufferers are at stage four, many potentially eligible for ventilator therapy. Currently, only about 60,000 Medicare beneficiaries receive this care, with overall market penetration near 10%. Viemed earns approximately $1,050 per month on average from each rented ventilator and has developed a connected platform to support telehealth visits and compliance documentation. The company is also diversifying its revenue streams. Sleep therapy grew by 44% in the prior year, while sleep resupply products increased by 47%. Viemed completed three acquisitions over the past three years, including Home Medical Products for $31 million and a joint venture with East Alabama Medical Center valued at $4.5 million.
